Related Experiment Video
Updated: Jan 30, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Vertically acquired occult hepatitis B virus infection may become overt after several years
Anders Eilard1, Maria Andersson1, Johan Ringlander1
1Department of Infectious Diseases, University of Gothenburg, 413 46 Gothenburg, Sweden.
Insights
Occult hepatitis B virus (HBV) infection can occur in infants despite vaccination and immunoglobulin. This vertical transmission may lead to overt HBV infection later in childhood.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis B virus (HBV) poses a significant global health challenge.
- Vertical transmission from mothers to infants is a primary route of HBV infection.
- Despite prophylaxis, occult HBV infection (OBI) remains a concern.
Purpose of the Study:
- To determine the frequency of vertically acquired occult HBV infection in infants born to HBsAg-positive mothers.
- To assess the long-term outcomes of OBI in children who received standard prophylaxis.
Main Methods:
- Investigated 44 infants born to HBsAg-positive mothers receiving HBV vaccine and HBIG (if HBeAg-positive).
- Analyzed HBV DNA at 6 weeks and 12 months, and HBV antibodies at 12 and 18 months.
- Followed up children at 5-7 years for serological markers and HBV DNA.
Main Results:
- Three children had detectable HBV DNA at 12 months, with sequences matching their mothers' HBV.
- One of these children developed HBsAg and anti-HBc positivity by 5-7 years.
- Two of the three children with initial OBI still had detectable HBV DNA at long-term follow-up.
Conclusions:
- Vertical transmission of HBV can result in OBI, even with adequate prophylaxis.
- OBI may progress to overt HBV infection, highlighting the need for continued monitoring.
- The clinical significance of OBI requires further investigation.
Objectives:
To study the frequency of vertically acquired occult hepatitis B virus (HBV) infection (OBI).
Methods:
We investigated 44 children born to hepatitis B surface antigen (HBsAg) positive mothers. They received HBV vaccine directly after birth and at 2, 6 and 52 weeks of age; eight with HBeAg-positive mothers also received hepatitis B immunoglobulin (HBIG). HBV DNA was analyzed in blood collected at 6 weeks and 12 months of age, and HBV antibodies at 12 and 18 months of age.
Results:
HBV DNA, but not HBsAg or anti-HBc, was detected at 12 months of age in three children. The viral sequences were almost identical with HBV DNA from their mothers who all were HBeAg-positive and had received tenofovir during pregnancy. Follow-up at 5-7 years age showed that one of the three children had become seropositive for HBsAg and anti-HBc. This child and one of the other two had detectable HBV DNA at the follow-up, with whole genome sequences identical to those in HBV from their mothers.
Conclusions:
Mothers-to-child transmission of HBV can, despite adequate prophylaxis, lead to OBI which may later develop into overt HBV infection. Whether such infections are of clinical importance needs to be further investigated.
More Related Videos
Related Concept Videos
Vertical Curve: Problem Solving
What are Viruses?
Introduction to Vertical Curves
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Elevation of Intermediate Points on Vertical Curves
Sight Distance in a Vertical Curve

